IKS IPO Close Today : What GMP, subscription status

The Inventurus Knowledge Solutions (IKS) IPO is set to close today with significant interest from investors. The IPO was opened for subscription on 12th December 2024 and subscribed over 42.9 times the total issue. Retail investors contributed 12.72 times of subscriptions, and the rest are applications from institutional and non-institutional investors. 

With the help of IKS IPO, the company is to raise ₹1,1,20 crore, and the price band for this offering is ₹1,265 to ₹1,329 per share. Almost 1.88 crore equity shares from promoters and other shareholders are issued for OFS (Offer for Sale). 

Explore the breakdown of current GMP, subscription status, listing expectations, and more on Inventurus Knowledge Solutions IPO.

Inventurus Knowledge Solutions IPO Details

IKS Grey Market Premium

The grey market premium (GMP) for IKS IPO has surged by 31.38% in the closing time. This impressive jump represents a positive outlook for investors regarding the listing of this issue. Moreover, the GMP is currently at ₹417, which indicates that we can expect the share to be listed at the estimated price of ₹1,746.   

Rekha Jhunjhunwala backed this surge in GMP by attracting investors’ interest in subscriptions. Moreover, there are several other trends contributing to increasing IKS grey market premium. These include a significant rise in subscriptions, higher demand by retail investors and positive market trends.     

IKS IPO Subscription Status

As discussed above, IKS IPO has been subscribed over 42.9 times. Explore the healthy subscription numbers across all categories to assess its expected listing performance. 

IKS Company Overview

Inventurus Knowledge Solutions Ltd. was registered in 2006 and is currently engaged in influencing healthcare services by handling administrative work. It offers services like document management, virtual medical scribing, and clinical support.

The company played a pivotal role in making it convenient for the patients to get treatment whenever they needed. As of now, IKS serves around 778 healthcare companies, and its primary customers are Texas Health Care PLLC and Mass General Brigham Inc. 

IKS Financial Performance

*Data is updated as of 16th December 2024.

Expected Listing Gains

IKS IPO allotment is to be finalised on 17th December 2024. But, as of now, investors have a positive outlook for this issue and expect the share to be listed at around ₹1,746. If market sentiments continue to be positive, we can expect more from this issue. 

The strong financial performance of Inventurus Knowledge Solutions will contribute to an increase in allottees’ wealth in the long term as well. Moreover, Inventurus Knowledge Solutions IPO is going to be listed on both the BSE (Bombay Stock Exchange) and NSE (National Stock Exchange). 

Inventurus Knowledge Solutions IPO Dates